Capitala Group’s Partnership with Veteran Leadership is a Prescription for Success

Rhea-AI Summary

Capitala Group announced a successful exit from its senior secured debt and minority equity investment in Option Rx, a specialty compounding pharmacy operator in the U.S. This investment, made in partnership with Cold Bore Capital, supported Option Rx's growth through acquisitions in various healthcare sectors including fertility and veterinary services. Adam Richeson from Capitala expressed pride in the exit coinciding with Veterans Day, highlighting the partnership's focus on preserving family-owned business legacies.

Positive

• Successful exit from a senior secured debt and equity investment in Option Rx.
• Investment supported Option Rx's expansion and acquisitions across the specialty pharmacy sector.

Negative

• None.

CHARLOTTE, N.C., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Capitala Group (“Capitala”), a leading provider of capital to lower middle market companies, announced today that it has successfully exited its senior secured debt and minority equity investment in Option Rx, an owner and operator of specialty compounding pharmacies across the United States.

Originally provided in partnership with Cold Bore Capital, the investment funded the company’s next phase of growth as it acquired specialty pharmacies across the country. Based out of Nashville, TN, Optio Rx currently specializes in providing medication and care in the fertility, veterinary, dermatology, hormone replacement and hospice industries.

“Everyone at Capitala is especially proud to announce this successful exit today, as we celebrate Veterans Day 2020, and our partnership with Cold Bore Capital in this deal,” stated Adam Richeson, Managing Director at Capitala. “Cold Bore Capital is a veteran-led private equity firm that partners exceptional business owners with elite military leaders to preserve the legacies of family-owned businesses like Optio Rx.”

About Capitala Group

Capitala Group is a $3.0 billion asset management firm that has been providing capital to lower middle market companies throughout North America for over twenty years. Since our inception in 1998, Capitala has invested in over 165 companies and seeks to partner with strong management teams to create value and generate superior risk-adjusted returns for our individual and institutional investors. For more information, definitions and details visit our website at www.CapitalaGroup.com.

Contacts:
Steve Arnall
CFO | Investor Relations
sarnall@capitalagroup.com

Katina Cole Jakubowski
Marketing | Communications
kjakubowski@capitalagroup.com

FAQ

What recent investment did Capitala Group exit?

Capitala Group announced its successful exit from its investment in Option Rx.

How did the investment in Option Rx impact Capitala Group?

The investment funded Option Rx's growth and acquisitions in specialty pharmacies across the U.S.

What sectors does Option Rx specialize in?

Option Rx specializes in fertility, veterinary, dermatology, hormone replacement, and hospice.

Who partnered with Capitala Group in the investment?

Cold Bore Capital partnered with Capitala Group in the investment in Option Rx.

When did Capitala Group announce the exit from Option Rx?

The announcement was made on November 11, 2020, coinciding with Veterans Day.